InfuSystems Holdings, Inc. (INFU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

AMZN beats Q2 estimates, but Q3 guidance disappoints. AWS faces margin pressure amid cloud competition. Hold existing ...

On a per-share basis, the Eau Claire, Wisconsin-based company said it had profit of 72 cents. The diversified production company that makes everything from household appliances to munitions posted ...

Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago. These ...

Sabre reported revenues of $687.2 million for the quarter ended June 30, 2025, which lagged the Zacks Consensus Estimate $705 ...

In the latest close session, Air Industries (AIRI) was down 1.77% at $3.33. This change lagged the S&P 500's daily gain of 0.78%. Meanwhile, the Dow gained 0.47%, and the Nasdaq, a tech-heavy index, ...

(BH) on Friday reported second-quarter net income of $50.9 million, after reporting a loss in the same period a year earlier.

Sezzle Inc. (SEZL) delivered earnings and revenue surprises of +18.97% and +3.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

HOUSTON (AP) — HOUSTON (AP) — Plains All American Pipeline L.P. (PAA) on Friday reported second-quarter earnings of $210 million. The Houston-based company said it had net income of 21 cents per share ...

WELLSBORO, Pa. (AP) — WELLSBORO, Pa. (AP) — Citizens & Northern Corp. (CZNC) on Friday reported net income of $6.1 million in its second quarter. The bank, based in Wellsboro, Pennsylvania, said it ...

Sabine Royalty Trust (SBR) on Friday reported earnings of $17.8 million in its second quarter. On a per-share basis, the Dallas-based company said it had net income of $1.

The pharmaceutical company posted revenue of $37.2 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $37.9 million. Heron Therapeutics expects ...